Key Cardiovascular Findings: Up to 18% reduction in serious cardiovascular events (heart attacks, strokes) Protection occurs regardless of weight loss amount Improved blood vessel function and reduced inflammation Benefits seen within 3-6 months of treatment initiation Reduced cardiovascular death risk As The Times of India reported (November 16, 2025): New research indicates Ozempic and Mounjaro offer significant cardiovascular benefits beyond weight loss and blood sugar control. Critical New Research: What Happens When You Stop

(Were seeing this echoed across clinical forums and digital health commentary, including recent discussions shared by Digital Health Insights.) That shift matters Because once clinicians start asking questions, regulators arent far behind - and programmes built for speed rather than structure begin to feel the pressure This is where the conversation with serious operators has changed: Away from access Toward execution How programmes are run How patients are supported long-term How compliance and dispensing hold up as volume increases GLP-1's are entering a phase where scale is assumed How cleanly you operate under that scale is not Thats the work we focus on #GLP1 #ClinicalGovernance #HealthcareInfrastructure #UKHealthcare #GPhC #DigitalHealth #BoltPharmacy #Mounjaro #Wegovy To view or add a comment, sign in The first oral GLP-1 is now available in the US
Ipamorelin and CJC 1295 Benefits Ipamorelin and CJC-1295 offer a range of potential benefits when used together
In a supplementation study of mice, Akkermansia reduces ALT and AST levels, mitigating future potential liver damage caused by overactivity of these enzymes
As it turns out, even when people get weight loss surgery, three years out, there is significant weight gain, Li said
If you experience vomiting or diarrhea lasting more than 24 hours, standard guidance for oral contraceptives recommends continuing backup contraception until you have taken your pill for seven consecutive days after symptoms resolve